Today: 12 May 2026
AMD stock ends down 1.7% at $200 — what investors are watching before Monday’s open
28 February 2026
2 mins read

AMD stock ends down 1.7% at $200 — what investors are watching before Monday’s open

New York, Feb 28, 2026, 10:46 EST — Market closed.

  • AMD shares slipped 1.7% by Friday’s close, with chip names broadly losing steam as Wall Street pulled back on AI-related positions.
  • Coming up next week: U.S. manufacturing numbers hit Monday, with the February jobs report following on Friday.
  • Traders are looking for new signals around AMD’s AI-chip demand—pricing details, too, plus what those recent mega-deals are costing the company.

Advanced Micro Devices (AMD.O) slipped 1.7% on Friday, settling at $200.21. The week wrapped up with shares under pressure as investors eyed what could drive the stock next.

Chip stocks stumbled, dragging the Philadelphia SE Semiconductor index down 1.2% and Nvidia (NVDA.O) off by 3.5%. The Nasdaq slipped 0.92%. “Time for a breather,” said Talley Leger, strategist at The Wealth Consulting Group, pointing to the sharp rally in semiconductors. Reuters

Timing is critical here. Rivalry in AI hardware keeps ramping up, and AMD’s valuation is still closely pegged to hopes for data-center expansion. Nvidia, for its part, is gearing up to roll out a new platform tailored to “inference”—the stage when AI models actually spit out answers. According to the Wall Street Journal, which cited sources familiar with the project, Nvidia’s move is in the works. Reuters

Macro wildcards aren’t off the table yet. With the U.S. February jobs numbers due March 6, investors are weighing the timing of the next Federal Reserve rate cut—while AI-fueled moves keep shaking up select sectors, according to a Reuters “Week Ahead” piece. Reuters

Manufacturing numbers kick off the week, with ISM’s factory report landing March 2 at 10 a.m. EST. That release has the potential to rattle Treasury yields—and with them, rate-sensitive growth stocks.

The labor market takes center stage Friday. The Bureau of Labor Statistics will release February’s employment numbers at 8:30 a.m. ET on March 6.

AMD is pushing to expand its AI business beyond just hyperscalers. The chipmaker unveiled a strategic partnership with Nutanix to develop what they describe as an “agentic AI” platform—software geared to handle tasks, not simply respond to prompts. AMD’s Dan McNamara emphasized that customers want “the freedom to run the models” on whichever infrastructure fits. Advanced Micro Devices, Inc.

The real weight comes from how massive — and how unusual — AMD’s new deal is. This week, AMD revealed plans to sell up to $60 billion in AI chips to Meta Platforms (META.O) over five years, with a twist: Meta gets the right to pick up as much as 10% of AMD itself. Hargreaves Lansdown analyst Matt Britzman summed up Meta’s approach as “doing whatever it takes” to keep chip shortages off the table. Reuters

Another filing drew some notice, though it wasn’t about a sale. AMD’s Chief Technology Officer Mark Papermaster shifted 413,212 shares into grantor retained annuity trusts, a typical estate-planning setup, according to a Form 4.

Sector sentiment is steering the action right now. Nvidia’s earnings didn’t light a fresh spark—now “It feels like an Nvidia hangover,” said Michael Green of Simplify Asset Management. The chip index dropped, with most of the pain showing up in the Nasdaq. Reuters

Even so, it doesn’t take much to lay out the bear case for AMD. Should AI infrastructure budgets tighten, or if the market’s patience for hefty spending without near-term returns wears thin, chip stocks with lofty forecasts can tumble fast — as Nvidia’s own shares just did after its latest numbers, despite the headline beat.

Investors eyeing AMD will be tuning in for demand signals and product updates when the company takes the stage at the Morgan Stanley Technology, Media & Telecom Conference on March 3, its investor relations calendar shows.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Sandisk stock price slides on insider sale filing; SNDK faces key dates next week
Previous Story

Sandisk stock price slides on insider sale filing; SNDK faces key dates next week

Applied Materials stock pulls back from $396 high as insider sale and March events put AMAT in focus
Next Story

Applied Materials stock pulls back from $396 high as insider sale and March events put AMAT in focus

Go toTop